Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Theramed Corporation, a subsidiary of Meta Health Services, has entered into a sales and distribution agreement with AstraZeneca Canada for the promotion of the blood pressure treatment Plendil, and Rhinocort, a nasal spray used to treat hay fever.
Subscribe to our email newsletter
As of November 2005, Theramed will use its sales force to promote and sell both products to targeted general practitioners and specialists throughout Canada, although it is expected that Theramed will have to undertake a significant expansion of its sales and marketing capability to support these products.
This agreement provides an opportunity for Theramed to augment its product portfolio and support the efforts of AstraZeneca to ensure that these proven and trusted medicines remain available to satisfy important patient needs in the future.
Under the terms of the agreement AstraZeneca Canada will continue to lead all medical information, regulatory affairs and drug safety activities.